Cargando…
mTOR Signaling in Metabolism and Cancer
The mechanistic/mammalian target of rapamycin (mTOR), a serine/threonine kinase, is a central regulator for human physiological activity. Deregulated mTOR signaling is implicated in a variety of disorders, such as cancer, obesity, diabetes, and neurodegenerative diseases. The papers published in thi...
Autor principal: | Huang, Shile |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7601420/ https://www.ncbi.nlm.nih.gov/pubmed/33065976 http://dx.doi.org/10.3390/cells9102278 |
Ejemplares similares
-
mTOR Signaling in Cardiometabolic Disease, Cancer, and Aging
por: Das, Anindita, et al.
Publicado: (2017) -
VEGF-mTOR signaling links obesity and endometrial cancer
por: Sahoo, Subhransu S., et al.
Publicado: (2018) -
mTOR Signaling in Cardiometabolic Disease, Cancer, and Aging 2018
por: Das, Anindita, et al.
Publicado: (2019) -
Targeting glutaminase and mTOR
por: Tanaka, Kazuhiro, et al.
Publicado: (2015) -
mTOR in cerebrovascular disease
por: Van Skike, Candice E., et al.
Publicado: (2019)